Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vivos Therapeutics, Inc. | 364,755 | reported | 26 Nov 2024 | tx 18+1,154,276 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Nov 2024 | GRANT_AWARD | Vivos Therapeutics, Inc. | 315,421 | 2.64 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Vivos Therapeutics, Inc. | 20,000 | 2.38 USD | deriv |
| 20 Jun 2023 | PURCHASE | Vivos Therapeutics, Inc. | 14,000 | 0.53 USD | |
| 16 Jun 2023 | PURCHASE | Vivos Therapeutics, Inc. | 5,000 | 0.53 USD | |
| 16 Jun 2023 | PURCHASE | Vivos Therapeutics, Inc. | 10,000 | 0.54 USD | |
| 15 Jun 2023 | PURCHASE | Vivos Therapeutics, Inc. | 21 | 0.50 USD | anomaly |
| 14 Jun 2023 | PURCHASE | Vivos Therapeutics, Inc. | 10,000 | 0.49 USD | |
| 23 Dec 2022 | PURCHASE | Vivos Therapeutics, Inc. | 20,000 | 0.50 USD | |
| 23 Dec 2022 | GRANT_AWARD | Vivos Therapeutics, Inc. | 150,000 | 0.48 USD | deriv |
| 23 Dec 2022 | GRANT_AWARD | Vivos Therapeutics, Inc. | 333,334 | 0.48 USD | deriv |
| 01 Jun 2022 | PURCHASE | Vivos Therapeutics, Inc. | 4,000 | 1.83 USD | |
| 31 May 2022 | PURCHASE | Vivos Therapeutics, Inc. | 8,000 | 2.03 USD | |
| 25 Feb 2022 | GRANT_AWARD | Vivos Therapeutics, Inc. | 125,000 | 3.27 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Vivos Therapeutics, Inc. | 125,000 | 5.64 USD | deriv |
| 21 Sept 2021 | PURCHASE | Vivos Therapeutics, Inc. | 5,000 | 4.31 USD | |
| 17 Aug 2021 | PURCHASE | Vivos Therapeutics, Inc. | 5,000 | 3.00 USD | |
| 25 May 2021 | PURCHASE | Vivos Therapeutics, Inc. | 4,000 | 5.38 USD | |
| 11 Dec 2020 | PURCHASE | Vivos Therapeutics, Inc. | 500 | 8.50 USD |